Literature DB >> 24681957

The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes.

C H O'Flanagan1, V A Morais2, W Wurst3, B De Strooper4, C O'Neill1.   

Abstract

PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson's disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1(-/-) mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1(-/-) mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1(-/-) cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24681957     DOI: 10.1038/onc.2014.81

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  PINK1 deficiency enhances autophagy and mitophagy induction.

Authors:  Rubén Gómez-Sánchez; Sokhna M S Yakhine-Diop; José M Bravo-San Pedro; Elisa Pizarro-Estrella; Mario Rodríguez-Arribas; Vicente Climent; Francisco E Martin-Cano; María E González-Soltero; Anurag Tandon; José M Fuentes; Rosa A González-Polo
Journal:  Mol Cell Oncol       Date:  2015-08-20

2.  Primary cilia and SHH signaling impairments in human and mouse models of Parkinson's disease.

Authors:  Sebastian Schmidt; Malte D Luecken; Dietrich Trümbach; Sina Hembach; Kristina M Niedermeier; Nicole Wenck; Klaus Pflügler; Constantin Stautner; Anika Böttcher; Heiko Lickert; Ciro Ramirez-Suastegui; Ruhel Ahmad; Michael J Ziller; Julia C Fitzgerald; Viktoria Ruf; Wilma D J van de Berg; Allert J Jonker; Thomas Gasser; Beate Winner; Jürgen Winkler; Daniela M Vogt Weisenhorn; Florian Giesert; Fabian J Theis; Wolfgang Wurst
Journal:  Nat Commun       Date:  2022-08-16       Impact factor: 17.694

3.  PARK2 regulates eIF4B-driven lymphomagenesis.

Authors:  Bandish B Kapadia; Anirban Roychowdhury; Forum Kayastha; Nahid Nanaji; Ronald B Gartenhaus
Journal:  Mol Cancer Res       Date:  2022-02-01       Impact factor: 6.333

4.  Pink1 promotes cell proliferation and affects glycolysis in breast cancer.

Authors:  Jing Li; Xuting Xu; Huilian Huang; Liqin Li; Jing Chen; Yunfeng Ding; Jinliang Ping
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-11

Review 5.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

Review 6.  PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease.

Authors:  Agne Kazlauskaite; Miratul M K Muqit
Journal:  FEBS J       Date:  2014-11-20       Impact factor: 5.542

Review 7.  Mitochondrial regulation of β-cell function: maintaining the momentum for insulin release.

Authors:  Brett A Kaufman; Changhong Li; Scott A Soleimanpour
Journal:  Mol Aspects Med       Date:  2015-02-07

8.  Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.

Authors:  Quan Xing Liu; Hong Zheng; Xu Feng Deng; Dong Zhou; Ji Gang Dai
Journal:  World J Surg Oncol       Date:  2015-08-07       Impact factor: 2.754

9.  PINK1, cancer and neurodegeneration.

Authors:  Ciara H O'Flanagan; Vanessa A Morais; Cora O'Neill
Journal:  Oncoscience       Date:  2016-01-12

Review 10.  The associations between Parkinson's disease and cancer: the plot thickens.

Authors:  Danielle D Feng; Waijiao Cai; Xiqun Chen
Journal:  Transl Neurodegener       Date:  2015-10-26       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.